日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775

乐伐替尼联合帕博利珠单抗治疗既往接受过治疗的晚期子宫内膜癌:随机、3期研究309/KEYNOTE-775的5年结果

Makker, Vicky; Colombo, Nicoletta; Casado, Antonio; Santin, Alessandro D; Colomba, Emeline; Miller, David S; Fujiwara, Keiichi; Pignata, Sandro; Yonemori, Kan; Kim, Yong Man; Baron-Hay, Sally; Ray-Coquard, Isabelle; Shapira-Frommer, Ronnie; Kristeleit, Rebecca; Nishio, Shin; Suzuki, Shiro; Guerra Alía, Eva M; Sanli, Ulus A; Selle, Frederic; Shikama, Ayumi; Martínez Rodríguez, Jorge L; Arik, Zafer; Arican, Ali; Sebastianelli, Alexandra; Yu, Zhou; McKenzie, Jodi; Kruger, Stephan; Meng, Robin; Okpara, Chinyere E; Lorusso, Domenica

PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer.

PCSK9 驱动胰腺癌中甾醇依赖性转移器官的选择。

Rademaker Gilles, Hernandez Grace A, Seo Yurim, Dahal Sumena, Miller-Phillips Lisa, Li Alexander L, Peng Xianlu Laura, Luan Changfei, Qiu Longhui, Liegeois Maude A, Wang Bruce, Wen Kwun W, Kim Grace E, Collisson Eric A, Kruger Stephan F, Boeck Stefan, Ormanns Steffen, Guenther Michael, Heinemann Volker, Haas Michael, Looney Mark R, Yeh Jen Jen, Zoncu Roberto, Perera Rushika M

Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers.

胰腺导管腺癌血清生物标志物组合诊断:可溶性白细胞介素、IFN-γ、TNF-α和PD-1/PD-L1与已建立的血清肿瘤标志物的临床应用价值比较

Dorman Klara, Gerckens Miriam, Kruger Stephan, Krueger Kimberly, Mayer Zsuzsanna, Rupp Alexander, Zhang Danmei, Weiss Lena, Westphalen C Benedikt, Haas Michael, Guenther Michael, Ormanns Steffen, Klawonn Frank, Werner Jens, von Bergwelt-Baildon Michael, Heinemann Volker, Boeck Stefan, Holdenrieder Stefan

Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 study

细菌脂多糖作为吉西他滨治疗晚期胰腺癌疗效的负性预测因子——来自 AIO-PK0104 III 期研究的转化结果

Guenther, Michael; Haas, Michael; Heinemann, Volker; Kruger, Stephan; Westphalen, Christoph Benedikt; von Bergwelt-Baildon, Michael; Mayerle, Julia; Werner, Jens; Kirchner, Thomas; Boeck, Stefan; Ormanns, Steffen

Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer

胰腺癌中组织蛋白酶D表达与吉西他滨耐药性

Mahajan, Ujjwal M; Goni, Elisabetta; Langhoff, Enno; Li, Qi; Costello, Eithne; Greenhalf, William; Kruger, Stephan; Ormanns, Steffen; Halloran, Christopher; Ganeh, Paula; Marron, Manuela; Lämmerhirt, Felix; Zhao, Yue; Beyer, Georg; Weiss, Frank-Ulrich; Sendler, Matthias; Bruns, Christiane J; Kohlmann, Thomas; Kirchner, Thomas; Werner, Jens; D'Haese, Jan G; von Bergwelt-Baildon, Michael; Heinemann, Volker; Neoptolemos, John P; Büchler, Markus W; Belka, Claus; Boeck, Stefan; Lerch, Markus M; Mayerle, Julia

Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox

晚期胰腺癌患者治疗启动时间延长对治疗结果无显著影响:一项控制了前置时间偏倚和等待时间悖论的回顾性队列研究

Kruger, Stephan; Schirle, Karoline; Haas, Michael; Crispin, Alexander; Schirra, Jörg; Mayerle, Julia; D'Haese, Jan G; Kunz, Wolfgang G; Ricke, Jens; Ormanns, Steffen; Kirchner, Thomas; Kobold, Sebastian; Ilmer, Matthias; Gebauer, Leonie; Westphalen, Christoph B; von Bergwelt-Baildon, Michael; Werner, Jens; Heinemann, Volker; Boeck, Stefan

Advances in cancer immunotherapy 2019 - latest trends

2019年癌症免疫疗法进展——最新趋势

Kruger, Stephan; Ilmer, Matthias; Kobold, Sebastian; Cadilha, Bruno L; Endres, Stefan; Ormanns, Steffen; Schuebbe, Gesa; Renz, Bernhard W; D'Haese, Jan G; Schloesser, Hans; Heinemann, Volker; Subklewe, Marion; Boeck, Stefan; Werner, Jens; von Bergwelt-Baildon, Michael

Awareness of predatory journals and open access among medical oncologists: results of an online survey

医学肿瘤学家对掠夺性期刊和开放获取的认知:一项在线调查的结果

Richtig, Georg; Richtig, Erika; Böhm, Alexandra; Oing, Christoph; Bozorgmehr, Farastuk; Kruger, Stephan; Kiesewetter, Barbara; Zielinski, Christoph; Berghoff, Anna S

POLE gene hotspot mutations in advanced pancreatic cancer

晚期胰腺癌中POLE基因热点突变

Guenther, Michael; Veninga, Vivien; Kumbrink, Joerg; Haas, Michael; Westphalen, C Benedikt; Kruger, Stephan; Heinemann, Volker; Kirchner, Thomas; Boeck, Stefan; Jung, Andreas; Ormanns, Steffen

Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer

扩展的 RAS 分析及其与晚期胰腺癌总生存期的相关性

Haas, Michael; Ormanns, Steffen; Baechmann, Sibylle; Remold, Anna; Kruger, Stephan; Westphalen, Christoph B; Siveke, Jens T; Wenzel, Patrick; Schlitter, Anna Melissa; Esposito, Irene; Quietzsch, Detlef; Clemens, Michael R; Kettner, Erika; Laubender, Ruediger P; Jung, Andreas; Kirchner, Thomas; Boeck, Stefan; Heinemann, Volker